Found 0 matching trials
Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease
PHASE3The purpose of this study is to determine the safety and efficacy of natali...
Location
Elan Pharmaceuticals
Motixafortide and Natalizumab to Mobilize CD34+ Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease (SCD)
PHASE1Hematopoietic stem cell (HSC)-based gene therapies now offer curative poten...
Location
Washington University School of Medicine
Sensation, Motion, and Quality of Life on Natalizumab and Off Natalizumab
NAThe goal of this proposal is to use the BeCare App to (1) determine changes...
Location
Mount Sinai Hospital
Magnetic Resonance Imaging (MRI) Follow-up of Macrophagic Infiltration in MS Patients Treated With Tysabri
PHASE4To evaluate the diagnosis value of MRI and positon emission tomography (PET...
Location
Service de Neurologie, Hôpital Civil, Hôpitaux Universitaires de Strasbourg
Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab
PHASE3The primary objective of the study is to evaluate the effects of treatment ...
Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)
N/ACLUE is a prospective study to assess structural and functional changes of ...
Location
Beijing Tiantan Hospital
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
N/AThe primary objective of the study is to determine the incidence and patter...
PK and PD Study of Natalizumab in Pediatric Subjects With RRMS
PHASE1The primary objective of the study is to determine the pharmacokinetic (PK)...
Ireland Natalizumab (TYSABRI) Observational Program
N/AThe objectives of this study are to assess the long-term safety and impact ...
Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis
PHASE4Multiple Sclerosis (MS) is the most common neurological disorder causing di...
Location
Ospedale Regionale di Lugano - Civico